Physician profile
Dylan A Levy
NPI 1437786837
$2,056.67
in general payments reported to CMS, 2019-2025
7 companies · $2,057 in 2025
The $2,057 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,083 · Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,082.66 |
| Food and Beverage | $974.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,671.23 | 2025 | Inspire |
| Aerin Medical INC. | $149.91 | 2025 | |
| Cochlear Americas | $84.53 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Genzyme Corporation | $68.81 | 2025 | |
| Paratek Pharmaceuticals, INC. | $42.60 | 2025 | Xhance |
| Takeda Pharmaceuticals U.S.A., INC. | $20.61 | 2025 | Cuvitru |
| Astrazeneca Pharmaceuticals LP | $18.98 | 2025 | Fasenra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.